ReviewJournal of thoracic disease2020
Classification and staging of thymoma.
Review in Journal of thoracic disease, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Effectiveness of Adjuvant Chemo- and Radiotherapy in Thymic Carcinoma Stage II: A Systematic Review and Meta-Analysis.Cancer control : journal of the Moffitt Cancer CenterPooled it
- A Rare Histologic Variant of Thymoma: Diagnostic Challenges of Micronodular Thymoma With Lymphoid Stroma.Cureus · 2026Article
- Immunohistochemical biomarker-associated radiomics for classifying thymic epithelial tumors: a multicenter retrospective study.NPJ precision oncology · 2026Article
- Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Thymomas under the radiomic lens: preliminary evidence of CT-radiomics signatures for histological grading and disease staging.La Radiologia medica · 2025Article
- Robot-Assisted Versus Open Surgery for the Resection of Large Thymomas: A Retrospective Cohort Study.Journal of surgical oncology · 2025Article
- Review
- Results of radiotherapy for thymoma: retrospective cohort and propensity score matching analysis.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2025Article
- Case Report: Type A invasive thymoma with renal metastasis.Frontiers in oncology · 2025Article
- Article
- Radical Removal of Low-Differentiation Thymic Squamous Cell Carcinoma: A Rare Clinical Case.Cureus · 2024Article
- Lobulated tumor contour as a predictor of preoperative tumor invasion of the lung or pericardium in thymoma patients.Surgery today · 2024Article
- Identification of cytokines in benign and malignant thymus tumors: based on Mendelian randomization and proteomics.Frontiers in endocrinology · 2024Article
- Thymoma: An Overview.Diagnostics (Basel, Switzerland) · 2023Review
- Thymoma: a fatal case report of recurring pneumonia from Tanzania.Annals of medicine and surgery (2012) · 2023Article
- Utility of non-contrast-enhanced magnetic resonance imaging in predicting preoperative clinical stage and prognosis in patients with thymic epithelial tumor.Japanese journal of radiology · 2023Article
- Thymic Epithelial Tumors: An Evolving Field.Life (Basel, Switzerland) · 2023Review
- Epigenetics of Thymic Epithelial Tumors.Cancers · 2023Review
- Guideline for the management of myasthenic syndromes.Therapeutic advances in neurological disorders · 2023Review
- Nomogram based on TNM stage to predict the prognosis of thymic epithelial tumors (TETs) patients undergoing extended thymectomy.Frontiers in surgery · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The appropriate therapy and prognosis of patients with thymic malignancies is decisively influenced by the local extent and dissemination of the tumor. For this reason, a staging system that reflects these factors is essential. Mainly the Masaoka-Koga classification, which was introduced in 1994, has been applied for this purpose. The rarity of thymic malignancies makes it difficult not only to establish internationally standardized diagnostics and treatment, but also to progress staging. Besides, efforts were made to adapt the classification into a tumor-node-metastasis-based (TNM) system for standardization with the staging of other tumor entities. The 2017 published 8th edition of the TNM Classification of Malignant Tumors introduced several adjustments based on a proposal of the International Association for the Study of Lung Cancer (IASLC) and the International Thymic Malignancy Interest Group (ITMIG). Compared to the Masaoka-Koga classification, surgically good resectable tumor involvements like pericardium, mediastinal fat or mediastinal pleura have been shifted to lower stages. Thus, even more than in Masaoka-Koga classification, tumors are basically divided into completely resectable and thus surgically treatable tumors (stage I, II, IIIA) and advanced stages (stage IIIB, IVA and IVB) that require multimodal therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.